Association study of BMP4, IL6, Leptin, MMP3, and MTNR1B gene promoter polymorphisms and adolescent idiopathic scoliosis

Spine

Volumn 36, Issue 2, 2011, Pages

  Mórocz, Mónika ^a   Czibula, Ágnes ^a   Grózer, Zsuzsanna B ^a   Szécsényi, Anita ^a   Álmos, Péter Z ^a   Raskó, István ^a   Illés, Tamás ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Adolescent idiopathic scoliosis; association study; PCRRFLP; promoter polymorphism

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; INTERLEUKIN 6; LEPTIN; MELATONIN 1B RECEPTOR; MELATONIN RECEPTOR; STROMELYSIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADOLESCENT DISEASE; ADOLESCENT IDIOPATHIC SCOLIOSIS; ARTICLE; BONE REMODELING; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUNGARY; IDIOPATHIC SCOLIOSIS; MAJOR CLINICAL STUDY; OSSIFICATION; PEDIGREE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; BONE MORPHOGENETIC PROTEIN 4; FEMALE; GENE FREQUENCY; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; LEPTIN; MALE; MATRIX METALLOPROTEINASE 3; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTOR, MELATONIN, MT2; SCOLIOSIS; YOUNG ADULT;

EID: 79551531401     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e318a511b0e     Document Type: Article

References (41)

1. Weinstein SL, Dolan LA, Cheng JCY, et al. Adolescent idiopathic scoliosis. Lancet 2008;371:1527-37.
2. Kouwenhoven JW, Castelein RM. The pathogenesis of adolescent idiopathic scoliosis: review of the literature. Spine 2008;33:2898-908.
3. Cheung KM, Wang T, Qiu GX, et al. Recent advances in the aetiology of adolescent idiopathic scoliosis. Int Orthop 2008;32:729-34.
4. Cheng JC, Tang NL, Yeung HY, et al. Genetic association of complex traits: using idiopathic scoliosis as an example. Clin Orthop Relat Res 2007;462:38-44.
5. Esposito T, Uccello R, Caliendo R, et al. Estrogen receptor polymorphism, estrogen content and idiopathic scoliosis in human: a possible genetic linkage. J Steroid Biochem Mol Biol 2009;116:56-60.
6. Aulisa L, Papaleo P, Pola E, et al. Association between IL-6 and MMP-3 gene polymorphisms and adolescent idiopathic scoliosis: a case-control study. Spine 2007;32:2700-2.
7. Qiu XS, Tang NL, Yeung HY, et al. Melatonin receptor 1B (MTNR1B) gene polymorphism is associated with the occurrence of adolescent idiopathic scoliosis. Spine 2007;32:1748-53.
8. Chakraborti S, Mandal M, Das S, et al. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003;253:269-85.
9. Takahashi M, Haro H, Wakabayashi Y, et al. The association of degeneration of the intervertebral disc with 5a/6a polymorphism in the promoter of the human matrix metalloproteinase-3 gene. J Bone Joint Surg Br 2001;83:491-5.
10. Thillard MJ. Vertebral column deformities following epiphysectomy in the chick. C.R. Hebd Seances Acad Sci 1959;248:1238-40.
11. Satomura K, Tobiume S, Tokuyama R, et al. Melatonin at pharmacological doses enhances human osteoblastic differentiation in vitro and promotes mouse cortical bone formation in vivo. J Pineal Res 2007;42:231-9.
12. Garcia-Maurino S, Pozo D, Calvo JR, et al. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J Pineal Res 2000;29:129-37.
13. Moreau A, Wang DS, Forget S, et al. Melatonin signaling dysfunction in adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 2004;29:1772-81.
14. Winnier G, Blessing M, Labosky PA, et al. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995;9:2105-16.
15. Canalis E, Economides AN, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 2003;24:218-35.
16. van den WA, Pijpers MA, Joosten PH, et al. Functional characterization of two promoters in the human bone morphogenetic protein- 4 gene. J Bone Miner Res 1999;14:1432-41.
17. van den WA, Mulder WR, Dijkema R, et al. Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells. Mol Endocrinol 2000;14:623-33.
18. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32.
19. Considine RV, Considine EL, Williams CJ, et al. Mutation screening and identifi cation of a sequence variation in the human ob gene coding region. Biochem Biophys Res Commun 1996;220:735-9.
20. Hoffstedt J, Eriksson P, Mottagui-Tabar S, et al. Polymorphism in the leptin promoter region (-2548 G/A) infl uences gene expression and adipose tissue secretion of leptin. Horm Metab Res 2002;34:355-9.
21. Mammes O, Betoulle D, Aubert R, et al. Association of the G- 2548A polymorphism in the 5 region of the LEP gene with overweight. Ann Hum Genet 2000;64:391-4.
22. Le Stunff C, Le Bihan C, Schork NJ, et al. common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes 2000;49:2196-200.
23. Yiannakouris N, Melistas L, Yannakoulia M, et al. The-2548G/A polymorphism in the human leptin gene promoter region is associated with plasma free leptin levels; interaction with adiposity and gender in healthy subjects. Hormones (Athens) 2003;2:229-36.
24. Matkovic V, Ilich JZ, Skugor M, et al. Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab 1997;82:3239-45.
25. Dong J, Ishimori N, Paigen B, et al. Role of modulator recognition factor 2 in adipogenesis and leptin expression in 3T3-L1 cells. Biochem Biophys Res Commun 2008;366:551-5.
26. Kim BC, Kim WY, Park D, et al. SNP@Promoter: a database of human SNPs (single nucleotide polymorphisms) within the putative promoter regions. BMC Bioinformatics 2008;9(suppl 1):S2.
27. NCBI GenBank database. Nucleic Acids Res 2008;36(Database issue):D25-30. http://www.ncbi.nlm.nih.gov.
28. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
29. Yapijakis C, Kechagiadakis M, Nkenke E, et al. Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer. J Cancer Res Clin Oncol 2009;135:603-12.
30. Hirose Y, Chiba K, Karasugi T, et al. A functional polymorphism in THBS2 that affects alternative splicing and MMP binding is associated with lumbar-disc herniation. Am J Hum Genet 2008;82:1122-9.
31. Yamada R, Tanaka T, Unoki M, et al. Association between a singlenucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximumlikelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease. Am J Hum Genet 2001;68:674-85.
32. Otto TC, Bowers RR, Lane MD. BMP-4 treatment of C3H10T1/2 stem cells blocks expression of MMP-3 and MMP-13. Biochem Biophys Res Commun 2007;353:1097-104.
33. Roberts S, Evans H, Trivedi J, et al. Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am 2006;88(suppl 2):10-4.
34. Stottmann RW, Berrong M, Matta K, et al. The BMP antagonist Noggin promotes cranial and spinal neurulation by distinct mechanisms. Dev Biol 2006;295:647-63.
35. Confavreux CB, Levine RL, Karsenty G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol 2009;310(1/2):21-9.
36. Cirmanova V, Bayer M, Starka L, et al. The effect of leptin on bone: an evolving concept of action. Physiol Res 2008;57(suppl 1):S143-51.
37. Qiu Y, Sun X, Qiu X et al. Decreased circulating leptin level and its association with body and bone mass in girls with adolescent idiopathic scoliosis. Spine (Phila Pa 1976) 2007;32:2703-10.
38. Jiang Y, Wilk JB, Borecki I, et al. Common variants in the 5 region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet 2004;75:220-30.
39. Ribeiro R, Araujo AP, Coelho A, et al. A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer. Eur J Cancer 2006;42:1188-93.
40. Skibola CF, Holly EA, Forrest MS, et al. Body mass index, leptin and leptin receptor polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2004;13:779-86.
41. Snoussi K, Strosberg AD, Bouaouina N, et al. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 2006;6:38.